Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeFDAEVA15 Insufflator and Smoke Evacuation System Receives FDA Clearance Annouces Palliare

EVA15 Insufflator and Smoke Evacuation System Receives FDA Clearance Annouces Palliare

Palliare announced today that it has received 510k clearance from the United States FDA for its patented EVA15 insufflator and smoke evacuation system.

EVA15 is a novel insufflator designed to meet the demanding insufflation requirements of endoscopic and robotic surgery, while offering integrated surgical smoke evacuation capability, filtering the hazardous smoke particles produced during laparoscopic surgery and removing them from the operating room. The built-in smoke evacuation capability also allows EVA15 to reduce device footprint in the OR by 50 percent while significantly reducing the cost of each procedure.

“EVA15 is the optimal solution for insufflation and surgical smoke evacuation, with one device managing two of the most critical needs for these types of surgical procedures,” said Caroline O’Dea, Managing Director, Palliare. “We are excited to receive FDA 510K clearance for EVA15, marking a crucial step toward bringing this important product to market later this year.”

The dangers associated with surgical smoke inhalation have been well documented, leading recently to a number of US states passing legislation mandating the use of such smoke evacuation systems to protect the safety of operating room staff. The American Association of periOperative Registered Nurses (AORN) estimates that being in an operating room for just one day has the potential to expose operating staff to surgical smoke that is equivalent to smoking 27 to 30 unfiltered cigarettes. The EVA15 laparoscopic insufflator provides pedal-activated smoke evacuation, and has the unique capability of connecting directly to the OR scavenging system, ensuring that smoke is completely removed from the operating room and not re-circulated.

Palliare is also pleased to announce two appointments to its Board of Directors. With more than 30 years of experience in the surgical industry, Scott D. Flora will serve as Chairman of the Board. Flora recently served as CEO of Invuity prior to its acquisition by Stryker (NYSE:SYK), and has previously served as President, Global Business Unit, Surgical Devices at Covidien (NYSE:MDT). Additionally, leading Irish Medtech entrepreneur John O’Shaughnessy will serve on Palliare’s Board of Directors. John was a co-founder and Chairman of Neuravi prior to its acquisition by Johnson & Johnson (NYSE:JNJ), and co-founder and CEO of MedNova prior to its acquisition by Abbott (NYSE:ABT).

“We are delighted to have Scott Flora and John O’Shaughnessy join the Palliare Board,” said O’Dea. “Palliare will greatly benefit from their significant experience as we prepare for the EVA15 product launch.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy